A detailed history of Erts Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Erts Wealth Advisors, LLC holds 6,300 shares of BMY stock, worth $370,062. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,300
Previous 6,300 -0.0%
Holding current value
$370,062
Previous $261,000 24.9%
% of portfolio
0.06%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $15,257 - $17,299
-318 Reduced 4.81%
6,300 $341,000
Q1 2023

Apr 18, 2023

SELL
$65.71 - $74.53 $36,140 - $40,991
-550 Reduced 7.67%
6,618 $458,000
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $7,190 - $8,514
-105 Reduced 1.44%
7,168 $515,000
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $86 - $51,329
668 Added 10.11%
7,273 $517,000
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $61,480 - $73,720
-1,000 Reduced 13.15%
6,605 $482,000
Q1 2021

May 07, 2021

BUY
$59.34 - $66.74 $53,999 - $60,733
910 Added 13.59%
7,605 $480,000
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $11,259 - $12,758
195 Added 3.0%
6,695 $415,000
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $26,130 - $28,956
-455 Reduced 6.54%
6,500 $392,000
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $5,482 - $6,409
-100 Reduced 1.42%
6,955 $409,000
Q4 2019

Feb 19, 2020

BUY
$49.21 - $64.19 $73,962 - $96,477
1,503 Added 27.07%
7,055 $453,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $270,715 - $351,052
5,552 New
5,552 $289,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Erts Wealth Advisors, LLC Portfolio

Follow Erts Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erts Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Erts Wealth Advisors, LLC with notifications on news.